ACO1 | Aconitase 1, soluble | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins
| | | | | Expressed in all |
ACVR1B | Activin A receptor, type IB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ACVR2B | Activin A receptor, type IIB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ADNP | Activity-dependent neuroprotector homeobox | Cancer-related genes Transcription factors
| | | | | Expressed in all |
AJUBA | Ajuba LIM protein | Cancer-related genes
| | | | | Tissue enhanced |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ANK3 | Ankyrin 3, node of Ranvier (ankyrin G) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ARHGAP35 | Rho GTPase activating protein 35 | Cancer-related genes
| | | | | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ARID5B | AT rich interactive domain 5B (MRF1-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ASXL2 | Additional sex combs like 2 (Drosophila) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes
| | | | | Group enriched |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BRE | Brain and reproductive organ-expressed (TNFRSF1A modulator) | Cancer-related genes
| | | | | Expressed in all |
C3orf70 | Chromosome 3 open reading frame 70 | Cancer-related genes
| | | | | Tissue enhanced |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
CARD11 | Caspase recruitment domain family, member 11 | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CBFB | Core-binding factor, beta subunit | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CCDC120 | Coiled-coil domain containing 120 | Cancer-related genes
| | | | | Mixed |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets
| | | | | Mixed |
CD1D | CD1d molecule | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Mixed |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CDC27 | Cell division cycle 27 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CDK4 | Cyclin-dependent kinase 4 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Cancer-related genes
| | | | | Expressed in all |
CDKN1B | Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CDKN2A | Cyclin-dependent kinase inhibitor 2A | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
CEP76 | Centrosomal protein 76kDa | Cancer-related genes
| | | | | Expressed in all |
CHD4 | Chromodomain helicase DNA binding protein 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CHD8 | Chromodomain helicase DNA binding protein 8 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CNBD1 | Cyclic nucleotide binding domain containing 1 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
CNKSR1 | Connector enhancer of kinase suppressor of Ras 1 | Cancer-related genes
| | | | | Tissue enhanced |